Bradesco: A Turnaround That Is Working, And Still Cheap Enough To Buy

Banco Bradesco is rated Buy with a 12-month price target of $4.15-$4.30, implying 18-22% upside from $3.52. The investment case rests on rising earnings, improved efficiency and a transition toward collateralized lending, while the insurance business provides steady returns. Elevated NPLs, macro headwinds and higher loan-loss provisions remain key risks to the banking turnaround.

Analysis

The investable question is whether BBD can convert better loan mix into a durable reduction in cost of risk before the market discounts a full-cycle recovery. A shift toward secured credit typically improves loss severity with a 2-4 quarter lag, creating operating leverage if provisioning normalizes while expense discipline holds. The insurance franchise should dampen earnings volatility and supports a sum-of-the-parts re-rating, but the market will require evidence that its cash generation is not merely offsetting recurring banking-credit losses.

The principal near-term variable is Brazil's real-rate and employment path: lower rates can support loan demand and treasury results, but rapid rate cuts may also compress asset yields before funding costs fully reprice. For the ADR, BRL/USD can dominate a modest local-equity gain; a 10% BRL decline would largely erase the stated upside for a dollar-based holder. Over 6-18 months, the upside case depends on BBD narrowing its profitability discount to ITUB through a sustained decline in credit-cost ratios rather than simply meeting a single-quarter earnings beat.

Consensus may underappreciate the asymmetry if legacy unsecured exposures are already substantially provisioned: incremental improvement in delinquency formation would flow disproportionately to earnings and capital return capacity. Conversely, elevated reported problem loans mean a weak labor market or renewed household leverage stress can force further reserve builds, keeping the valuation discount intact. The thesis is falsified by two consecutive quarters of rising provisions or weaker secured-loan growth, particularly if management protects earnings through lower coverage rather than genuine credit improvement.

Key Decisions for Investors

• Initiate a measured 6-12 month long BBD position only on confirmation that quarterly cost of risk is declining and secured lending is growing faster than total loans; target the $4.15-$4.30 ADR range, with risk discipline if provisions reaccelerate for two quarters.
• For a sector-relative expression, consider long BBD / short ITUB in equal dollar amounts over 6-12 months after the next earnings release confirms credit-cost improvement. The trade isolates turnaround-driven multiple convergence, but exit if ITUB maintains superior return-on-equity while BBD's reserve burden fails to improve.
• Hedge ADR currency exposure through BRL/USD forwards or options where mandate permits; retain the hedge until Brazilian fiscal and inflation data demonstrate that easing can proceed without renewed BRL pressure.
• Do not underwrite the full valuation upside solely from insurance stability. Monitor quarterly insurance earnings, dividend/upstreaming capacity, loan-loss provisions, and coverage ratios; deterioration in any combination should convert the name from a buy candidate to a watch item rather than an averaged-down position.